Mulga snake (Pseudechis australis) envenoming: A spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy-Australian Snakebite Project (ASP-19)

Clinical Toxicology

Volumn 51, Issue 5, 2013, Pages 417-424

  Johnston, C I ^a,b   Brown, S G A ^c   O'Leary, M A ^d   Currie, B J ^e   Greenberg, R ^f   Taylor, M ^g   Barnes, C ^h   White, J ⁱ   Isbister, G K ^b,d  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e ROYAL DARWIN HOSPITAL   (Australia)

^f Dubbo Base Hospital   (Australia)

^g Albury Base Hospital   (Australia)

^h Wide Bay Hospital and Health Service   (Australia)

ⁱ WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Antivenom; Black snake; Coagulopathy; Envenoming; Haemolysis; Mulga snake; Myotoxicity; Pseudechis australis; Venom

Indexed keywords

CREATINE KINASE; SNAKE VENOM ANTISERUM;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANTICOAGULANT COAGULOPATHY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; CHEST TIGHTNESS; CHILD; CLINICAL ARTICLE; DYSPNEA; ENVENOMATION; ENZYME IMMUNOASSAY; FEMALE; HEMOLYSIS; HUMAN; HYPERSENSITIVITY; HYPOTENSION; HYPOXIA; MALE; MUSCLE DISEASE; MYOTOXICITY; PRESCHOOL CHILD; PSEUDECHIS AUSTRALIS; SNAKE; TREATMENT RESPONSE; URTICARIA;

ADOLESCENT; ADULT; AGED; ANTIVENINS; AUSTRALIA; BLOOD COAGULATION DISORDERS; CHILD; ELAPID VENOMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; NEUROTOXINS; PROSPECTIVE STUDIES; SNAKE BITES; TREATMENT OUTCOME; YOUNG ADULT;

ACACIA ANEURA; PSEUDECHIS AUSTRALIS; SERPENTES;

EID: 84878279625     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.787535     Document Type: Article

References (31)

1. Sutherland SK, Tibballs J. Genus Pseudechis, Black Snakes. Australian Animal Toxins . Melbourne: Oxford University Press ; 2001:137-159.
2. Broad AJ, Sutherland SK, Coulter AR. The lethality in mice of dangerous Australian and other snake venom. Toxicon 1979; 17:661-664.
3. Chen SZ, Gopalakrishnakone P, Gwee MC. Pharmacological effects and pathological changes induced by the venom of Pseudechis australis in isolated skeletal muscle preparations . Toxicon 1994 ; 32 : 303-315.
4. Ponraj D, Gopalakrishnakone P. Morphological changes induced by a generalized myotoxin (myoglobinuria-inducing toxin) from the venom of Pseudechis australis (king brown snake) in skeletal muscle and kidney of mice. Toxicon 1995; 33:1453-1467.
5. Lane J, O'Leary MA, Isbister GK. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro eff cacy of commercial anti-venom. Toxicon 2011; 58:239-246.
6. Dambisya YM, Lee TL, Gopalakrishnakone P. Anticoagulant effects of Pseudechis australis (Australian king brown snake) venom on human blood: a computerized thromboelastography study . Toxicon 1995; 33:1378-1382.
7. Takasaki C, Tamiya N. Isolation and amino acid sequence of a short-chain neurotoxin from an Australian elapid snake, Pseudechis austra-lis. Biochem J 1985; 232:367-371.
8. St Pierre L, Masci PP, Filippovich I, Sorokina N, Marsh N, Miller DJ, Lavin MF . Comparative analysis of prothrombin activators from the venom of Australian elapids. MolBiolEvol 2005; 22:1853-1864.
9. Sharp PJ, Berry SL, Spence I, Howden ME. A basic phospholipase A from the venom of the Australian king brown snake (Pseudechis aus-tralis) showing diverse activities against membranes . Comp Biochem Physiol B 1989; 92:501-508.
10. Fatehi M, Rowan EG, Harvey AL. An electrophysiological study on the effects of Pa-1G (a phospholipase A(2)) from the venom of king brown snake, Pseudechis australis, on neuromuscular function . Toxi-con 2002; 40:69-75.
11. Rowlands JB, Mastaglia FL, Kakulas BA, Hainsworth D. Clinical and pathological aspects of a fatal case of mulga (Pseudechis australis) snakebite. Med J Aust 1969; 1:226-230.
12. Campbell CH. Myotoxic paralysis and hemolytic anemia due to king brown snake bite. Aust N Z J Med 1984; 14:169.
13. Isbister GK, Currie BJ. Suspected snakebite: one year prospective study of emergency department presentations . EmergMed(Fremantle). 2003; 15:160-169.
14. Currie BJ. Snakebite in tropical Australia: a prospective study in the "Top End" of the Northern Territory. Med J Aust 2004; 181:693-697.
15. White J . A review of 105 cases of suspected snakebite in South Australia. In: Gopalakrishnakone P, Tan C, eds. Progress in Venom and Toxin Research . Singapore: National University of Singapore ; 1987 : 15-19 .
16. Churchman A, O'Leary MA, Buckley NA, Page CB, Tankel A, Gav-aghan C , et al . Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11) . Med J Aust 2010 ; 193:696-700.
17. Ramasamy S, Isbister GK, Hodgson WC. The eff cacy of two antiven-oms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation . Toxi-con 2004; 44:837-845.
18. Johnston CI, O'Leary MA, Brown SG, Currie BJ, Halkidis L, Whitaker R , et al . Death adder envenoming causes neurotoxicity not reversed by antivenom-Australian snakebite project (ASP-16) . PLoS Negl Trop Dis 2012; 6:e1841.
19. Allen GE, Brown SG, Buckley NA, O'Leary MA, Page CB, Currie BJ , et al . Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming-Australian snakebite project (ASP-14). PLoS One 2012; 7:e53188.
20. Isbister GK, White J, Currie BJ, et al. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12). Toxicon 2011; 58:634-640.
21. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the def nition and management of anaphylaxis: summary report-Second. National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117:391-397.
22. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114:371-376.
23. Kulawickrama S, O'Leary MA, Hodgson WC, Brown SG, Jacoby T, Davern K, Isbister GK. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum . Toxicon 2010 ; 55:1510-1518.
24. Isbister GK, Hooper MR, Dowsett R, Maw G, Murray L, White J. Collett ' s snake (Pseudechis colletti) envenoming in snake handlers . QJM 2006; 99:109-115.
25. Isbister GK. Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 2010; 36:444-451.
26. Bailey PM, Bakker AJ, Seymour JE, Wilce JA. A functional comparison of the venom of three Australian jellyfsh-Chironex f eckeri, Chi-ropsalmus sp., and Carybdea xaymacana-on cytosolic Ca2+, haemolysis and Artemia sp. lethality. Toxicon 2005; 45:233-242.
27. Isbister JP. Blood volume, Haematocrit and Hemorheology: The interrelationships. Clin Hemorheol 1994; 14:15.
28. Isbister GK, O'Leary MA, Elliott M, Brown SG. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13) . Med J Aust. 2012; 197:173-177.
29. O'Leary MA, Isbister GK. Commercial monovalent antivenoms in Australia are polyvalent. Toxicon 2009; 54:192-195.
30. Isbister GK, Brown SGA. Bites in Australian snake handlers-Australian snakebite project (ASP-15). QJM 2012; (in press).
31. Isbister GK, Brown SG, MacDonald E, White J, Currie BJ; Australian Snakebite Project Investigators . Current use of Australian snake anti-venoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 2008; 188:473-476.